Integrative multi-omics analysis identifies SNRPE as a key driver gene in Uterine corpus endometrial carcinoma: promoting tumor progression, and mediating immune evasion

To investigate the role of SNRPE in tumor progression and immune evasion in Uterine Corpus Endometrial Carcinoma (UCEC).

SNRPE is identified as an oncogene linked to poor survival outcomes in UCEC.
Knocking down SNRPE significantly suppressed tumor progression.
SNRPE maintains accurate splicing of dual-function hub genes, affecting oncogenic signaling and immune surveillance.
SNRPE induces an immune evasion phenotype by reducing major histocompatibility complex class I expression and enhancing immunosuppressive signaling.
Silencing SNRPE restores T cell-mediated cytotoxicity and reverses exhaustion marker expression.

SNRPE plays a dual role in promoting tumor growth and facilitating immune evasion in UCEC by remodeling the splicing network.

The study relies on specific cohorts which may not be generalizable to all UCEC patients.
Further in vivo studies are needed to fully understand the therapeutic potential of targeting SNRPE.

SNRPE is a critical regulator of tumor progression and immune evasion in UCEC, suggesting it as a potential therapeutic target.